Patricia S. Andrews

Chief Commercial Officer, Incyte.

Companies

Geron CorporationBoard member Mar 26, 2026 to now¹
Oncolytics BiotechBoard member Jan 2, 2026 to now²
CRESCENT BIOPHARMA, INC.Board member Jun 12, 2017 to May 1, 2024³
IncyteChief Commercial Officer Oct 23, 2008 to Jan 23, 2012⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CRESCENT BIOPHARMA, INC. CBIO58,608 shares⁵$730.8K at $12.47Dec 29, 2023
Oncolytics Biotech ONCY78,128 shares⁶$39.2K at $0.50Feb 12, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 12, 2026Bought 35,400 shares at $0.86 of Oncolytics Biotech⁶
Dec 29, 2023Granted 5,191 shares at $2.36 of CRESCENT BIOPHARMA, INC.⁵
Sep 30, 2023Granted 8,167 shares at $1.50 of CRESCENT BIOPHARMA, INC.⁷
Nov 16, 2021Bought 40,000 shares at $2.05 of CRESCENT BIOPHARMA, INC.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGeron Corporation, Board member
2
SEC EDGAROncolytics Biotech, Board member
3
SEC EDGARCRESCENT BIOPHARMA, INC., Board member
4
SEC EDGARIncyte, Chief Commercial Officer
5
SEC EDGARCRESCENT BIOPHARMA, INC. shares after the filing of Dec 29, 2023
6
SEC EDGAROncolytics Biotech shares after the filing of Feb 12, 2026
7
SEC EDGARForm 4 filed Oct 3, 2023
8
SEC EDGARForm 4 filed Nov 18, 2021